Cari L Tsinovoi1, Pengcheng Xun1, Leslie A McClure1, Vivian M O Carioni1, John D Brockman1, Jianwen Cai1, Eliseo Guallar1, Mary Cushman1, Frederick W Unverzagt1, Virginia J Howard1, Ka He2. 1. From the Departments of Epidemiology and Biostatistics (C.L.T., P.X., K.H.) and Psychiatry (F.W.U.), Indiana University, Bloomington; Department of Epidemiology and Biostatistics, Drexel University, Philadelphia, PA (L.A.M.); University of Missouri Research Reactor Center, University of Missouri, Columbia (V.M.O.C., J.D.B.); Department of Biostatistics, University of North Carolina at Chapel Hill (J.C.); Department of Epidemiology, Johns Hopkins University, Baltimore, MD (E.G.); Department of Medicine, Larner College of Medicine at the University of Vermont, Burlington (M.C.); and Department of Epidemiology, University of Alabama at Birmingham (V.J.H.). 2. From the Departments of Epidemiology and Biostatistics (C.L.T., P.X., K.H.) and Psychiatry (F.W.U.), Indiana University, Bloomington; Department of Epidemiology and Biostatistics, Drexel University, Philadelphia, PA (L.A.M.); University of Missouri Research Reactor Center, University of Missouri, Columbia (V.M.O.C., J.D.B.); Department of Biostatistics, University of North Carolina at Chapel Hill (J.C.); Department of Epidemiology, Johns Hopkins University, Baltimore, MD (E.G.); Department of Medicine, Larner College of Medicine at the University of Vermont, Burlington (M.C.); and Department of Epidemiology, University of Alabama at Birmingham (V.J.H.). kahe@indiana.edu.
Abstract
BACKGROUND AND PURPOSE: The purpose of this case-cohort study was to examine urinary arsenic levels in relation to incident ischemic stroke in the United States. METHODS: We performed a case-cohort study nested within the REGARDS (REasons for Geographic and Racial Differences in Stroke) cohort. A subcohort (n=2486) of controls was randomly sampled within region-race-sex strata while all incident ischemic stroke cases from the full REGARDS cohort (n=671) were included. Baseline urinary arsenic was measured by inductively coupled plasma-mass spectrometry. Arsenic species, including urinary inorganic arsenic and its metabolites monomethylarsonic acid and dimethylarsinic acid, were measured in a random subset (n=199). Weighted Cox's proportional hazards models were used to calculate hazard ratios and 95% confidence intervals of ischemic stroke by arsenic and its species. RESULTS: The average follow-up was 6.7 years. Although incident ischemic stroke showed no association with total arsenic or total inorganic arsenic, for each unit higher level of urinary monomethylarsonic acid on a log-scale, after adjustment for potential confounders, ischemic stroke risk increased ≈2-fold (hazard ratio=1.98; 95% confidence interval: 1.12-3.50). Effect modification by age, race, sex, or geographic region was not evident. CONCLUSIONS: A metabolite of arsenic was positively associated with incident ischemic stroke in this case-cohort study of the US general population, a low-to-moderate exposure area. Overall, these findings suggest a potential role for arsenic methylation in the pathogenesis of stroke, having important implications for future cerebrovascular research.
RCT Entities:
BACKGROUND AND PURPOSE: The purpose of this case-cohort study was to examine urinary arsenic levels in relation to incident ischemic stroke in the United States. METHODS: We performed a case-cohort study nested within the REGARDS (REasons for Geographic and Racial Differences in Stroke) cohort. A subcohort (n=2486) of controls was randomly sampled within region-race-sex strata while all incident ischemic stroke cases from the full REGARDS cohort (n=671) were included. Baseline urinary arsenic was measured by inductively coupled plasma-mass spectrometry. Arsenic species, including urinary inorganic arsenic and its metabolites monomethylarsonic acid and dimethylarsinic acid, were measured in a random subset (n=199). Weighted Cox's proportional hazards models were used to calculate hazard ratios and 95% confidence intervals of ischemic stroke by arsenic and its species. RESULTS: The average follow-up was 6.7 years. Although incident ischemic stroke showed no association with total arsenic or total inorganic arsenic, for each unit higher level of urinary monomethylarsonic acid on a log-scale, after adjustment for potential confounders, ischemic stroke risk increased ≈2-fold (hazard ratio=1.98; 95% confidence interval: 1.12-3.50). Effect modification by age, race, sex, or geographic region was not evident. CONCLUSIONS: A metabolite of arsenic was positively associated with incident ischemic stroke in this case-cohort study of the US general population, a low-to-moderate exposure area. Overall, these findings suggest a potential role for arsenic methylation in the pathogenesis of stroke, having important implications for future cerebrovascular research.
Authors: Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sandeep R Das; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Carmen R Isasi; Monik C Jiménez; Suzanne E Judd; Brett M Kissela; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David J Magid; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Wayne Rosamond; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Daniel Woo; Robert W Yeh; Melanie B Turner Journal: Circulation Date: 2016-01-26 Impact factor: 29.690
Authors: Audrey R Matteson; Travis W Gannon; Matthew D Jeffries; Stephanie Haines; Dustin F Lewis; Matthew L Polizzotto Journal: J Environ Qual Date: 2014-01 Impact factor: 2.751
Authors: Yan Yuan; Guillermo Marshall; Catterina Ferreccio; Craig Steinmaus; Steve Selvin; Jane Liaw; Michael N Bates; Allan H Smith Journal: Am J Epidemiol Date: 2007-09-17 Impact factor: 4.897
Authors: Cheng Chen; Pengcheng Xun; Cari Tsinovoi; Leslie A McClure; John Brockman; Leslie MacDonald; Mary Cushman; Jianwen Cai; Lisa Kamendulis; Jason Mackey; Ka He Journal: Neurology Date: 2018-06-22 Impact factor: 9.910